CAR-T | CHOP Research Institute


Published on
May 11, 2022
In this Q&A, Stephan Grupp, MD, PhD, discusses his experience delivering CAR T-cell therapy to the first pediatric patient, Emily Whitehead.
Published on
Nov 3, 2021
The peptide-centric CAR T cells, or PC-CARS, target cancer drivers in tumor cells previously thought unreachable.

Shifting the paradigm to treat the toughest pediatric cancers with new cell therapies that reprogram a patient's own immune system to kill cancer cells.

Published on
Oct 8, 2018
An infographic and article look at the science behind gene therapy, challenges faced by the field, and the road ahead.
Published on
Sep 20, 2018
Two exciting lines of research build on what we know about hemophilia to improve existing treatments.